Olmesartan 20 mg Tablet (Olmesartan Medoxomil)
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samchundang Pharm. Co., Ltd.
MFDS item code 201100918 · Approved 2011.02.24
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension
Essential hypertension refers to a condition where blood pressure is consistently high without any specific cause. This medication helps lower blood pressure and relieve vascular tension, aiding in the control of hypertension. Consistent use is also effective in preventing complications such as heart disease or stroke. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, taken with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg per day. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect reached after approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients taking diuretics, particularly those with renal impairment), treatment should preferably be initiated at a low dose, with their condition monitored closely. <Elderly patients> No dose adjustment is necessary when administering this medicine to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be excluded. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg per day. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.
This medication may cause serious harm or death to the fetus and newborn if administered to pregnant women in the second or third trimester, so treatment should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any ingredients in this medication, pregnant or breastfeeding women, patients undergoing renal dialysis, patients with severe liver dysfunction, patients with biliary obstruction, etc., should not take this medication. Patients with lactose intolerance should avoid this medication due to lactose content. Patients with reduced blood volume or body salt may experience initial hypotension after taking this medication, so they should carefully observe their condition before taking it and monitor blood pressure closely during treatment. Patients with severe heart failure or impaired renal function may experience worsening kidney function when taking this medication, so regular blood tests should monitor kidney status and electrolyte levels. Patients with renal artery stenosis may have an increased risk of worsening kidney function after taking this medication, so caution is warranted. This medication can increase blood potassium levels, so patients with heart or kidney disease should have their potassium levels checked regularly. Special caution is needed for patients with aortic or mitral stenosis, obstructive or hypertrophic cardiomyopathy when taking this medication. Patients with primary aldosteronism may not respond well to this medication, and its use is not recommended. This medication may cause dizziness, so caution should be exercised when driving or operating hazardous machinery. While this medication is generally safe to use, some patients may experience mild side effects such as dizziness, headache, abdominal pain, muscle pain, or rash. Rare side effects have also been reported, including severe allergic reactions, angioedema, liver function abnormalities, and acute renal failure, so patients should consult medical professionals immediately if any unusual symptoms occur. When taken with other antihypertensive drugs, potassium-sparing diuretics, or potassium supplements, there is a risk of dangerously elevated blood potassium levels, so caution is advised. Taking it with non-steroidal anti-inflammatory drugs may worsen kidney function, so adequate hydration and monitoring of kidney function are necessary during treatment. It is not recommended to use this medication in combination with lithium formulations, as it can increase lithium levels in the blood and pose a toxic risk. Pregnant women should not take this medication due to the risk of severe side effects occurring in the fetus, and breastfeeding women should either stop nursing or discontinue the medication. The safety of this medication has not been fully established for children, so it should be administered to children with caution. Elderly patients may show higher concentrations of this medication in the body, so caution is needed when administering it to this group. In case of overdose, symptoms such as hypotension and palpitations may occur, and if symptoms are severe, immediate medical treatment is required. This medication has not been reported to pose any carcinogenic or genotoxic risks even with long-term use; however, if any unusual symptoms occur, consultation with a specialist should be sought immediately.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to maintain storage temperatures between 1 to 25 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samchundang Pharm. Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
JW Pharmaceutical Corp.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
JW Pharmaceutical Corporation

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
DongKook Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.